Medical News

RSS

Bacteria dupe human immune system by using invisibility cloak

Scientists at the University of York have characterised an important new step in the mechanism used by bacteria to evade our immune system.

20 Feb 2008

In-hospital heart attacks during the night or weekends may lower survival rate

Patients who have an in-hospital cardiac arrest at night or on the weekend have a substantially lower rate of survival to discharge than hospitalized patients who experience a cardiac arrest during day/evening times on weekdays, according to a study in the February 20 issue of JAMA: The Journal of the American Medical Association.

20 Feb 2008

Human stem cells aid stroke recovery in rats

Neural cells derived from human embryonic stem cells helped repair stroke-related damage in the brains of rats and led to improvements in their physical abilities, according to a new study by researchers at the Stanford University School of Medicine.

20 Feb 2008

Most maternal deaths worldwide are preventable

A study published in PLoS Medicine this week suggests that of women who die during pregnancy and childbirth in sub-Saharan Africa, more may die from treatable infectious diseases than from conditions directly linked to pregnancy.

20 Feb 2008

U.S. hospital helps lower infection rates at British hospital

Using their best practice methods for infection control and patient care, Hospital for Special Surgery in New York has helped a new British hospital lower their infection rates and average length of stay.

20 Feb 2008

Ocular melanoma - potential new treatment options

Ocular melanoma is rarely detected before it has grown large enough to impair vision or to metastasize.

20 Feb 2008

$Hormone refractory prostate cancers more likely to spread to other organs$

Hormone refractory prostate cancers more likely to spread to other organs

Prostate cancers that are resistant to androgen deprivation therapy are more invasive and more likely to spread to other organs than androgen dependent prostate cancers, UCLA cancer researchers have found.

20 Feb 2008

Stereotypes and misinformation about HIV still commonplace in healthcare

The doctor who wouldn't come into the patient's hospital room. The neurologist who avoided eye contact. The ambulance attendant who angrily threw her bloodied gloves into the street after learning the injured patient was HIV-positive.

20 Feb 2008

Gene therapy - immune system discovery may lead to effective treatment for glioblastoma multiforme

A new gene therapy approach that attracts and "trains" immune system cells to destroy deadly brain cancer cells also provides long-term immunity, produces no significant adverse effects and -- in the process of destroying the tumor -- promotes the return of normal brain function and behavioral skills, according to a study conducted by researchers at Cedars-Sinai Medical Center's Board of Governors Gene Therapeutics Research Institute.

20 Feb 2008

FDA approves XYZAL (levocetirizine dihydrochloride) for allergies and chronic idiopathic urticaria

UCB and sanofi-aventis have announced that the U.S. Food and Drug Administration (FDA) approved a New Drug Application (NDA) for XYZAL (levocetirizine dihydrochloride) 0.5 mg/mL oral solution, a prescription antihistamine indicated for the relief of symptoms associated with indoor and outdoor allergies, as well as the treatment of chronic idiopathic urticaria.

20 Feb 2008

Families need help coping with mild cognitive impairment

The age-related memory condition known as mild cognitive impairment (MCI) is more disruptive of day-to-day life and relationships than once believed, gerontology researchers at Virginia Tech have discovered.

20 Feb 2008

Evidence supports bats as SARS virus source

Scientists who have studied the genome of the virus that caused severe acute respiratory syndrome (SARS) say their comparisons to related viruses offer new evidence that the virus infecting humans originated in bats.

20 Feb 2008

L-acetyl carnitine effective ADHD treatment for children with fragile X syndrome

Fragile X syndrome (FXS) is the most common hereditary form of mental retardation.

20 Feb 2008

Chronic exposure to beta-blockers attenuates inflammation and mucin content in asthma model

Inverseon, Inc. has announced the publication of a rapid communication of groundbreaking research led by Professor Richard Bond of the University of Houston, Inverseon's Scientific Founder.

20 Feb 2008

Different treatments for acute kidney failure often have similar outcomes

An analysis of studies examining treatments for acute kidney failure indicates that intermittent hemodialysis and continuous kidney replacement therapy appear to lead to similar clinical outcomes, including a similar risk of death, according to an article in the February 20 issue of JAMA: The Journal of the American Medical Association.

20 Feb 2008

Children show goal-oriented behavior by age 3

Hang on, parents. After the terrible twos come the goal-oriented threes.

20 Feb 2008

Risk factors for Parkinson's disease focus of new research

A new study demonstrates that high levels of MAO-B, an enzyme that regulates nerve activity in the brain, cause Parkinson's-like symptoms in mice genetically engineered to overexpress the protein.

20 Feb 2008

Biannual mass antibiotic treatment may help reduce contagious eye disease trachoma in Africa

Changing the administration of the antibiotic azithromycin from once to twice a year in villages in Ethiopia substantially reduced eye infections in preschool children caused by chlamydia, which causes the serious, contagious eye disease trachoma, according to a study in the February 20 issue of JAMA.

20 Feb 2008

Barr receives approval for generic Mirapex tablets

Barr Pharmaceuticals, Inc. has announced that its subsidiary, Barr Laboratories, Inc., has received final approval from the U.S. Food and Drug Administration (FDA) for its generic version of Boehringer Ingelheim Pharmaceuticals, Inc.'s Mirapex Tablets (Pramipexole Dihydrochloride) 0.125mg, 0.25mg, 0.5mg, 1mg & 1.5mg.

20 Feb 2008

Australian neuroscientist tests Chantix

UQ pharmacy graduate Dr Selena Bartlett is starting clinical trials of a new drug that could potentially curb addictions such as smoking, drinking, gambling even depression.

20 Feb 2008